Fåhraeus Startup and Growth is a venture capital fund established in 2021 and based in Lund, Sweden. The firm focuses on early-stage investments in life science and technology companies. By targeting emerging firms in these sectors, Fåhraeus aims to support innovation and growth, providing the necessary capital and expertise to help startups develop their ideas and bring products to market.
Airsonett is a medical device company focused on developing non-pharmaceutical treatments for allergic asthma and eczema. Its flagship product, the Air4, utilizes patented Temperature-controlled Laminar Airflow (TLA) technology to significantly reduce allergens and airborne irritants in a patient's breathing zone during rest and sleep. This innovative home medical device aims to provide relief for individuals suffering from allergic asthma and atopic eczema, primarily serving patients in Sweden and the UK. By offering a non-invasive solution, Airsonett addresses the need for effective prophylactic treatments without relying on traditional medication.
Oncorena
Venture Round in 2021
Oncorena AB is a pharmaceutical company based in Göteborg, Sweden, dedicated to developing innovative treatments for cancer, specifically advanced or metastatic renal cancer. The company is focused on the compound orellanine, a toxin derived from certain mushroom species, which has demonstrated potent anti-tumor activity. Oncorena's primary objective is to confirm the efficacy and clinical benefits of orellanine in targeting renal proximal tubular epithelial cells that have transformed into cancer cells and formed metastases. By harnessing the selective properties of this compound, Oncorena aims to provide effective pharmacological solutions for patients suffering from advanced kidney cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.